Skip to main content

On-Demand Webinar: FDA's Role in AST and Understanding CLSI Breakpoint Decisions

Learn about the FDA’s role in increasing the availability and reliability of antimicrobial susceptibility tests, then learn more about CLSI’s Rationale Documents. What are they? How can you use them?

John Farley, MD, MPHUS, Deputy Director, Office of Antimicrobial Products, US Food and Drug Administration

Romney Humphries, PhD, D(ABMM), Chief Scientific Officer, Accelerate Diagnostics Inc.